PROTON PUMP INHIBITORS VS HISTAMINE TYPE 2 RECEPTOR BLOCKERS FOR STRESS ULCER PROPHYLAXIS IN MECHANICALLY VENTILATED PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

被引：0
|
作者：
Banna, Soumya [1 ]
Schenck, Christopher [1 ]
Namburar, Sathvik [1 ]
Shahu, Andi [1 ]
Thomas, Alexander W. [1 ]
Heck, Cory [1 ]
Ali, Tariq [1 ]
Miller, Paul Elliott [1 ]
机构：
[1] Yale New Haven Hosp, New Haven, CT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1453-139
引用
收藏
页码：1276 / 1276
页数：1
相关论文
共 50 条
  • [11] Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
    Myung Jin Song
    Seok Kim
    Dachung Boo
    Changhyun Park
    Sooyoung Yoo
    Ho Il Yoon
    Young-Jae Cho
    Scientific Reports, 11
  • [12] Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients
    Hammond, Drayton A.
    Kathe, Niranjan
    Shah, Anuj
    Martin, Bradley C.
    PHARMACOTHERAPY, 2017, 37 (01): : 43 - 53
  • [13] Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients
    Putnam, Justin
    Wolfson, Allan B.
    ACADEMIC EMERGENCY MEDICINE, 2020, 27 (07) : 634 - 636
  • [14] Use of Proton Pump Inhibitors and Histamine Type 2 Receptor Blockers Is Not Associated with Pneumonia Risk
    Dublin, Sascha
    Walker, Rod L.
    Jackson, Michael L.
    Nelson, Jennifer C.
    Weiss, Noel S.
    Jackson, Lisa A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S18 - S19
  • [15] The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: A meta-analysis
    Lin, Pei-Chin
    Chang, Chia-Hsuin
    Hsu, Ping-I
    Tseng, Pi-Lai
    Huang, Yaw-Bin
    CRITICAL CARE MEDICINE, 2010, 38 (04) : 1197 - 1205
  • [16] Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation The PEPTIC Randomized Clinical Trial
    Young, Paul J.
    Bagshaw, Sean M.
    Forbes, Andrew B.
    Nichol, Alistair D.
    Wright, Stephen E.
    Bailey, Michael
    Bellomo, Rinaldo
    Beasley, Richard
    Brickell, Kathy
    Eastwood, Glenn M.
    Gattas, David J.
    Van Haren, Frank
    Litton, Edward
    Mackle, Diane M.
    McArthur, Colin J.
    McGuinness, Shay P.
    Mouncey, Paul R.
    Navarra, Leanlove
    Opgenorth, Dawn
    Pilcher, David
    Saxena, Manoj K.
    Webb, Steve A.
    Wiley, Daisy
    Rowan, Kathryn M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (07): : 616 - 626
  • [17] A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU
    Boyd, Carly
    Hassig, Tanna
    MacLaren, Robert
    PHARMACOTHERAPY, 2021, 41 (10): : 820 - 827
  • [18] Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically III Patients: A Systematic Review and Meta-Analysis
    Alhazzani, Waleed
    Alenezi, Farhan
    Jaeschke, Roman Z.
    Moayyedi, Paul
    Cook, Deborah J.
    CRITICAL CARE MEDICINE, 2013, 41 (03) : 693 - 705
  • [19] PROTON PUMP INHIBITORS VS H2 ANTAGONISTS FOR STRESS ULCER PROPHYLAXIS: IS THERE A ROLE FOR NEPHROPROTECTION?
    Akella, Krishna
    Chow, Priscilla
    Young, Daisy
    Tatarian, Liana
    Joshi, Gunjan
    Ibrahim, Samer
    Boden, Brian
    Sklarek, Howard
    Hussain, Kashif
    Chendrasekhar, Akella
    CHEST, 2019, 156 (04) : 1026A - 1027A
  • [20] Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients
    Jung, R
    MacLaren, R
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (12) : 1929 - 1937
12345